Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease
Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease
Recruiting · NCT06386497 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease | Dyssomnias, Parkinson disease, Sleep Disorders, Intrinsic, basal ganglia disorder, brain disorder, central nervous system disorder, insomnia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, sleep-wake disorder, synucleinopathy | Recruiting | Not applicable | 2026-05-22 | NCT06386497 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ETH Zurich | 27 |
| Insel Gruppe AG, University Hospital Bern | 224 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ETH Zurich, Sensory-Motor Systems Lab, IRIS | Zurich | Switzerland | 1 |
| Insel Gruppe AG, University Hospital Bern | Bern | Switzerland | 1 |